| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue | 10 | 151 | 1,510 | (1,187) | | | Gross Profit | (10) | (151) | (1,510) | 1,187 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,700 | 478 | (999) | 3,229 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,710) | (628) | (511) | (2,042) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (1,710) | (628) | (511) | (2,042) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,710) | (628) | (511) | (2,042) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,710) | (628) | (511) | (2,042) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,710) | (628) | (511) | (2,042) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,710) | ($628) | ($511) | ($2,042) |
|
0.02% Nasdaq 0.00%
Income Statement
